ARTICLE | Clinical News
Advate octocog alfa regulatory update
May 21, 2012 7:00 AM UTC
Baxter said China's State Food and Drug Administration (SFDA) approved Advate octocog alfa to control and prevent bleeding episodes in hemophilia A patients. The recombinant Factor VIII ( rFVIII) is n...